Moxie has entered into a Strategic Alliance Agreement with Organic Remedies MO, Inc ("ORMO") to produce and distribute Moxie's award-winning cannabis products to medicinal cannabis patients in the State of Missouri.
The agreement expands access to cannabis medicines throughout Missouri and continues Moxie's record of establishing productive partnerships across the United States. The company will work with and advise ORMO as they use their local expertise to produce cannabis medicines and expand access to treatments for Missouri residents across the state.
"Our alliance with ORMO marks the next chapter of Moxie's mission to provide Missouri residents with access to the highest quality medicinal cannabis products, as we continue to work towards making medicinal cannabis accessible to patients across the United States," said Jordan Lams, CEO and founder of Moxie. "Our agreement will bring the full suite of Moxie products to Missouri patients, and we're confident that we'll continue to set the standard for product quality, consistency, and patient care. Teaming up with the best-in-class operators of both cultivation, manufacturing, and retail at ORMO will swiftly provide patients with the same quality and assortment of Moxie products that customers in California have access to, which have come to be trusted and loved by cannabis consumers nationwide."
"We are thrilled for the opportunity to partner with Moxie," commented Mark Toigo, CEO of ORMO. "With Moxie's determination to provide clean, socially conscious, and masterfully curated cannabis, partnered with our own commitment to unlocking the untapped potential of medical cannabis therapies, our patients in Missouri will have access to an incredible product in Moxie, MO."
Missouri's medical cannabis marketplace is estimated by MJBizDaily Factbook to be worth between $375M-$450M in 2022 and as much as $600M in 2023. Legal Missouri 2022 recently submitted 400,000 signatures for a legalization initiative, putting their adult-use cannabis initiative before voters on the November 2022 ballot. If passed, the initiative constitutional amendment would allow for the use and possession of cannabis for adults 21 and older, and sales to commence in early 2023.